Priscilla Ramos Freitas
Overview
Explore the profile of Priscilla Ramos Freitas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Freitas P, Araujo A, Araujo I, Almeida R, Oliveira Borges J, Lima C, et al.
Biochimie
. 2024 Dec;
231:104-109.
PMID: 39708974
Thiadiazines are heterocyclic compounds known for some pharmacological activities. However, the ability of these compounds and their derivatives to act as antibacterial agents and inhibitors of the efflux system in...
2.
de Almeida R, Freitas P, Araujo A, Tintino S, Ribeiro-Filho J, Miranda G, et al.
Biomed Pharmacother
. 2024 Oct;
180:117600.
PMID: 39476763
This study aimed to evaluate the effects of liposome-encapsulated eugenol-based thiazolic derivatives against efflux pump-carrying bacteria. The Minimum Inhibitory Concentration (MIC) was determined to evaluate the antibacterial activity and antibiotic...
3.
Araujo A, Freitas P, Araujo I, Oliveira Borges J, Goncalves S, Paulo C, et al.
Curr Microbiol
. 2024 Aug;
81(10):325.
PMID: 39182011
Antimicrobials fight microorganisms, preventing and treating infectious diseases. However, antimicrobial resistance (AMR) is a growing concern due to the inappropriate and excessive use of these drugs. Several mechanisms can lead...
4.
de Sousa Ferreira F, de Araujo Neto J, Datiane de Morais Oliveira-Tintino C, Araujo A, Ribeiro-Filho J, Freitas P, et al.
Chem Biol Interact
. 2023 Oct;
386:110751.
PMID: 37821044
Multidrug resistance is a significant health problem worldwide, with increasing mortality rates, especially in the last few years. In this context, a consistent effort has been made to discover new...
5.
Araujo A, Freitas P, Araujo I, Siqueira G, Oliveira Borges J, Alves D, et al.
Fundam Clin Pharmacol
. 2023 Aug;
38(1):84-98.
PMID: 37649138
Background: Thiadiazines are heterocyclic compounds that contain two nitrogen atoms and one sulfur atom in their structure. These synthetic molecules have several relevant pharmacological activities, such as antifungal, antibacterial, and...
6.
Costa da Silva M, de Araujo Neto J, Lucas Dos Santos A, Datiane de Morais Oliveira-Tintino C, Araujo A, Freitas P, et al.
Plants (Basel)
. 2023 Apr;
12(8).
PMID: 37111810
, , and are the primary bacteria that cause clinical infections, such as urinary and intestinal infections, pneumonia, endocarditis, and sepsis. Bacterial resistance is an innate natural occurrence in microorganisms,...
7.
Datiane de Morais Oliveira-Tintino C, Tintino S, Araujo A, Rodrigues Dos Santos Barbosa C, Freitas P, de Araujo Neto J, et al.
Molecules
. 2023 Feb;
28(4).
PMID: 36838807
The bacterial species presents a variety of resistance mechanisms, among which the expression of β-lactamases and efflux pumps stand out for providing a significant degree of resistance to clinically relevant...
8.
Dias K, Miranda G, Bessa J, Araujo A, Freitas P, de Almeida R, et al.
Front Pharmacol
. 2022 Oct;
13:953982.
PMID: 36313340
Managing antibiotic resistance is a significant challenge in modern pharmacotherapy. While molecular analyses have identified efflux pump expression as an essential mechanism underlying multidrug resistance, the targeted drug development has...
9.
Leandro M, Barbosa Moura J, Araujo A, Freitas P, Paulo C, de Sousa A, et al.
Bioinorg Chem Appl
. 2022 Jul;
2022:2260083.
PMID: 35855788
The present study reports the synthesis, characterization, and antibacterial properties of silver trimolybdate (AgMoO.2HO) nanorods. The synthesis was performed using a conventional hydrothermal method. The sample was characterised by scanning...
10.
Pinheiro P, Santiago G, Freitas da Silva F, Araujo A, de Oliveira C, Freitas P, et al.
Biotechnol Rep (Amst)
. 2022 Mar;
34:e00717.
PMID: 35284249
Background: Bacterial resistance to multiple drugs has recently emerged as a serious health problem. Concomitantly, the characterization of new substances with potential antimicrobial activity has been less frequent in the...